FSSAI filed three adjudication cases against Nestlé India over infant nutrition products.
The regulator cited a laboratory finding on biotin content in a follow-up formula.
It also flagged promotional claims about human milk oligosaccharides and whey protein.
Nestlé India said its products and labels fully comply with food safety laws.
The company said the labels had prior approval from an expert committee.
A quick read on shared facts, changing details, and different emphasis.
The reporting broadly agrees that FSSAI has taken legal action against Nestlé India over infant nutrition products and that the company rejects the allegations. The accounts also agree that the dispute involves both promotional claims and a laboratory finding on biotin content.
What remains unresolved is how the cases will be adjudicated and whether the regulator's findings on biotin content will stand. Nestlé India’s defense centers on prior approval and compliance, but the final outcome is not yet reported.
Swipe through the perspectives. Labels describe coverage framing, not truth or quality.
The neutral coverage consistently reports that FSSAI has initiated three adjudication cases involving infant nutrition products. It includes the regulator's allegations about promotional claims and a biotin-related lab finding, along with Nestlé India's statement that its products comply with regulations. One account adds that the company says the labels were previously approved by an expert committee.
The latest eight dated reports, from earliest to newest.
BW Businessworld
indiantelevision.com
BusinessToday Malaysia
Attributed summaries from official party channels. These are claims, not independent reporting or fact checks.
Scan each source take, then open the original article.
The Food Safety and Standards Authority of India has filed three separate adjudication cases against Nestle India concerning three infant nutrition products. According to the regulator, a follow-up formula sample failed laboratory analysis for biotin content, while promotional material for two other products allegedly violated advertising restrictions. Nestle India stated that its products are fully compliant with regulations and that the labels had prior approval from an expert committee, though the company did not directly address the biotin finding.
The Food Safety and Standards Authority of India has initiated legal action against Nestle India by filing three adjudication cases over alleged regulatory violations in infant nutrition products. The regulator cited promotional claims regarding human milk oligosaccharides and whey protein on certain products, alongside a laboratory finding of substandard biotin content in a follow-up formula. Nestle India responded that its products and labels fully comply with applicable food safety laws and received prior approval from an FSSAI expert committee.
The Food Safety and Standards Authority of India has initiated three adjudication cases against Nestle India regarding regulatory compliance for three infant nutrition items. The action involves promotional claims on e-commerce platforms for specific products as well as a referral laboratory finding concerning biotin levels in a follow-up formula. Nestle India maintained that its products comply with regulations, asserting that the product labels were previously approved by an expert committee and are supported by scientific literature.